Verwendung: Dieses Produkt ist ausschließlich für Forschungszwecke bestimmt.
Alle Produktinformationen auf dieser Website dienen ausschließlich Bildungszwecken. Jede Form der Einbringung in den Körper von Menschen oder Tieren ist gesetzlich streng verboten. Dieses Produkt darf nur von zugelassenen und qualifizierten Fachleuten gehandhabt werden. Es ist kein Arzneimittel, Lebensmittel oder Kosmetikum und darf nicht als solches gekennzeichnet, verwendet oder falsch etikettiert werden.
Phenibut HCL – Powder, 50 grams
Während der Umstellung unserer Verpackung erhalten Sie möglicherweise Produkte mit dem bisherigen oder dem neuen Etikett. Formulierung, Reinheit und Qualität bleiben nach unseren Standards genau gleich.
- Kreditkarte
- Banküberweisung (SEPA Echtzeit)
- Banküberweisung (ACH)
- Wise
- Revolut
- Zelle
- Remitly
- Western Union
- Chime
- Andere
-25% auf alles – bis 31. Oktober
25% auf reguläre Preise statt anderer Angebote. Nur mit dem Krypto-Zahlungsrabatt kombinierbar.
Jede Charge wird auf Reinheit, Wirksamkeit und Qualität geprüft.
Laborergebnisse ansehen →Phenibut HCL powder (50 g) provides a bulk format of β-phenyl-γ-aminobutyric acid hydrochloride for research applications requiring solution preparation, dose titration, or formulation studies. The compound acts as a GABA-B agonist and GABA-A ρ receptor modulator. The powder format enables flexible concentration preparation and is suited to pharmacokinetic studies, in vitro assays, and custom formulation research protocols.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
3D Molecular Structure
Drag to rotate · scroll to zoom| Chemical Formula | C10H14ClNO2 |
|---|---|
| Synonyms | 4-Amino-3-phenylbutanoic acid Phenibut 1078-21-3 Fenibut 4-Amino-3-phenylbutyric acid |
| Molar Mass | 215.67 g/mol |
| CAS Number | 3060-41-1 |
| PubChem CID | 11499499 |
| Total Compound Content | 50 g powder |
| Shelf Life | 36 months |
Results refer to the tested sample. Check the batch and date in the report.
What distinguishes the powder format from capsule formulations in research applications?
The powder format provides greater flexibility for analytical investigations, solution preparation, concentration standardization, and formulation development. Researchers can prepare solutions at precisely defined concentrations for biochemical assays, receptor-binding studies, and other laboratory applications.
This versatility makes the powder format particularly useful for experimental designs requiring custom concentrations or multiple formulation conditions.
What are the solubility characteristics of Phenibut HCL powder?
Phenibut HCL is highly water-soluble due to its hydrochloride salt form and is also compatible with a variety of commonly utilized laboratory solvent systems. Its favorable solubility profile supports solution preparation, analytical characterization, formulation studies, and investigations of physicochemical properties.
These characteristics make Phenibut HCL a convenient compound for research involving dissolved preparations and solution-based experimental systems.
How does Phenibut differ from baclofen in receptor pharmacology research?
Both Phenibut and baclofen are investigated for interactions with GABA-B receptors, but they exhibit distinct pharmacological and structural characteristics. Phenibut has also been reported to interact with GABA-A ρ (rho) receptor systems, providing a broader receptor interaction profile than baclofen.
These differences make Phenibut a useful research tool for comparative investigations of receptor selectivity, ligand-receptor interactions, GABAergic signaling mechanisms, and structure-activity relationships within GABA-related compounds.
